Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.

LTH Jacobsson, C Turesson, A Gülfe… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To investigate the risk of cardiovascular disease (CVD) in patients with rheumatoid
arthritis (RA) treated with tumor necrosis factor (TNF) inhibitors, compared to a standard …

Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register

LE Kristensen, A Gülfe, T Saxne… - Annals of the rheumatic …, 2008 - ard.bmj.com
Background: The use of tumour necrosis factor (TNF) blocking agents in psoriatic arthritis (PsA)
is increasing, and the SSATG register has followed patients with PsA for more than 5 …

Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment …

LE Kristensen, MC Kapetanovic, A Gülfe… - …, 2008 - academic.oup.com
Objective. To identify factors predicting response to first TNF blocking treatment course in
patients with established RA with a special focus on gender differences. Methods. Patients with …

Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register

…, LE Kristensen, MC Kapetanovic, A Gülfe… - …, 2008 - academic.oup.com
Objectives. To study treatment response rates of RA patients undergoing second- and third-line
anti-TNF therapy and to identify baseline predictors of response to second-line treatment…

Continuation of TNF blockade in patients with inflammatory rheumatic disease. An observational study on surgical site infections in 1,596 elective orthopedic and hand …

E Berthold, P Geborek, A Gülfe - Acta orthopaedica, 2013 - Taylor & Francis
Background Increased infection risk in inflammatory rheumatic diseases may be due to
inflammation or immunosuppressive treatment. The influence of tumor necrosis factor (TNF) …

Recurrent fever caused by Candidatus Neoehrlichia mikurensis in a rheumatoid arthritis patient treated with rituximab

K Andréasson, G Jönsson, P Lindell, A Gülfe… - …, 2015 - academic.oup.com
SIR, It has been reported that RA can be successfully treated using rituximab (RTX) without
an increased risk of serious infections [1]. Candidatus Neoehrlichia mikurensis (CNM) is a tick…

Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohort

…, R Christensen, JA Karlsson, A Gülfe… - Arthritis care & …, 2014 - Wiley Online Library
Objective To study the impact of swollen to tender joint count ratio (STR) and other baseline
characteristics on treatment response to a first course of anti–tumor necrosis factor (anti‐TNF…

National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients

…, M Neovius, LE Kristensen, A Gülfe… - Annals of the …, 2011 - ard.bmj.com
Objective To study how the choice of national EQ-5D tariff may affect utility and incremental
quality-adjusted life-year (QALY) estimates. Methods South Swedish rheumatoid arthritis …

[HTML][HTML] Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with …

A Gülfe, D Aletaha, T Saxne, P Geborek - BMC Musculoskeletal Disorders, 2009 - Springer
Background Most composite indices of disease activity and response criteria in RA have been
validated and compared in clinical trials rather than routine care. We therefore wanted to …

[HTML][HTML] Anti-rheumatic treatment and prosthetic joint infection: an observational study in 494 elective hip and knee arthroplasties

Y Borgas, A Gülfe, M Kindt, A Stefánsdóttir - BMC Musculoskeletal …, 2020 - Springer
Background Surgical site infections are more frequent among patients with rheumatic disease.
To what extent this is related to immunosuppressive antirheumatic drugs is unclear, as is …